ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

0.661
0.00
(0.00%)
Closed April 20 4:00PM
0.00
0.00
(0.00%)

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.661
Bid
0.565
Ask
0.5878
Volume
-
0.00 Day's Range 0.00
0.6116 52 Week Range 24.196
Market Cap
Previous Close
0.661
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
150,797
Shares Outstanding
1,242,098
Dividend Yield
-
PE Ratio
-0.01
Earnings Per Share (EPS)
-53.07
Revenue
131.12M
Net Profit
-65.92M

About Acorda Therapeutics Inc

Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system... Acorda Therapeutics Inc is a biopharmaceutical company focused on developing therapies that restore function and improve the lives of people with neurological disorders. Acorda uses scientific, clinical, and commercial expertise in neurology as strategic points of access in additional nervous system markets, including stroke, Parkinson's disease, and epilepsy. The company does not operate separate lines of business with respect to any of its products or product candidates. All of its net product revenue is derived from the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Acorda Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ACOR. The last closing price for Acorda Therapeutics was $0.66. Over the last year, Acorda Therapeutics shares have traded in a share price range of $ 0.6116 to $ 24.196.

Acorda Therapeutics currently has 1,242,098 shares outstanding. The market capitalization of Acorda Therapeutics is $819,785 . Acorda Therapeutics has a price to earnings ratio (PE ratio) of -0.01.

ACOR Latest News

Acorda Therapeutics Announces Delisting from Nasdaq

Acorda Therapeutics, Inc. today announced that its common stock is no longer listed on the Nasdaq Stock Market. The delisting is a result of the Company’s failure to demonstrate compliance with...

Acorda Therapeutics Announces Nasdaq Delisting Notification

Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that Nasdaq Stock Market ("Nasdaq") today notified the Company that it will suspend trading in and delist the Company's common stock, effective...

Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement

Acorda Files for Voluntary Chapter 11 Protection to Facilitate Orderly Sale Acorda Enters into a Restructuring Support Agreement with over 90% of the Secured Convertible Noteholders Patient...

Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end 2023 earnings conference call originally scheduled for Monday, April 1 at 4:30...

Acorda Fourth Quarter/Year End 2023 Update: Webcast/Conference Call Scheduled for April 1, 2024

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced a webcast/conference call in conjunction with its fourth quarter and year end 2023 update and financial results for Monday, April 1 at...

Acorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced it will regain global commercialization rights to FAMPYRA® (fampridine) following a decision by Biogen to terminate the license and...

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

INBRIJA® (levodopa inhalation powder) Q3 2023 U.S. net revenue of $8.1 million; 4% increase over Q3 2022 AMPYRA® (dalfampridine) Q3 2023 net revenue of $15.7 million; 26% decrease over Q3 2022...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
4-11.829-94.70776621312.4913.740.61165610011.9011498CS
12-16.289-96.100294985316.9517.240.61161507972.10979886CS
26-9.399-93.429423459210.06180.6116689742.49292141CS
52-10.335-93.988723172110.99624.1960.611624814415.03430528CS
156-83.339-99.213095238184127.20.611671487227.22067634CS
260-1326.539-99.95019590111327.214580.61161350258146.39317146CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWGTop Wealth Group Holding Ltd
$ 3.73
(101.62%)
36.52M
CSLRComplete Solaria Inc
$ 0.465319
(75.59%)
16.64M
SHOTWSafety Shot Inc
$ 0.48
(60.00%)
6.71k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
MNDRMobile health Network Solutions
$ 27.2386
(33.72%)
10.35M
YYAIConnexa Sports Technologies Inc
$ 0.8943
(-57.21%)
13.4M
SBFMSunshine Biopharma Inc
$ 1.77
(-46.69%)
11.9M
GTIGraphjet Technology
$ 6.43
(-33.09%)
95.33k
ISPCiSpecimen Inc
$ 0.2883
(-31.52%)
2.86M
BGLCBioNexus Gene Lab Corporation
$ 0.5998
(-29.32%)
735.88k
EGOXNext e GO NV
$ 0.0515
(43.06%)
333.3M
SQQQProShares UltraPro Short QQQ
$ 12.84
(6.38%)
219.91M
AGBAAGBA Group Holding Ltd
$ 1.255
(21.84%)
128.79M
TQQQProShares UltraPro QQQ
$ 49.48
(-6.20%)
125.4M
SINTSiNtx Technologies Inc
$ 0.0414
(3.50%)
109.94M

ACOR Discussion

View Posts
Renee Renee 1 week ago
ACOR changed to ACORQ, bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
👍️0
Monksdream Monksdream 1 week ago
ACOR new 52 week lo

👍️0
J-mak J-mak 1 week ago
Is this a gap between 10 and 4?
👍️0
Monksdream Monksdream 1 week ago
ACOR new 52 lo
👍️0
willlbone willlbone 1 week ago
Squirrel buried this ACORn.
👍️0
Monksdream Monksdream 1 week ago
ACOR new 52 lo
👍️0
Monksdream Monksdream 2 weeks ago
ACOR new 52 lo
👍️0
Monksdream Monksdream 2 weeks ago
ACOR new 52 week low
👍️0
Firestorm22 Firestorm22 2 weeks ago
Definitely not a good sign
👍️0
Disquisition Disquisition 3 weeks ago
HORRENDOUS DUMPING
👍️0
INFINITI INFINITI 11 months ago
Boom time
👍️0
INFINITI INFINITI 11 months ago

On May 10, 2023, Acorda Therapeutics, Inc. (the “Company”) issued a press release announcing that the Company will make a cash interest payment of approximately $6.2 million in satisfaction of the interest payment due on June 1, 2023, as provided for under the indenture governing the Company’s 6.00% Convertible Senior Secured Notes due 2024 (the “Notes”). The Company will make the interest payment using cash that was placed in escrow when the Notes were issued, which is reported on the Company’s balance sheet as restricted cash. The June 1 payment is the last payment in which the Company has the option to pay in cash or shares of its common stock. All future payments will be made in cash. A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
👍️0
INFINITI INFINITI 11 months ago
Looking Good here for a nice bounce $$$$
👍️0
81vette 81vette 11 months ago
ZERO BORROW since 11:30,fee 33%with NO REBATE,tomorrow could be even better run
👍️0
81vette 81vette 11 months ago
Held up insanely well,still .10 over parabolic,great strength for confidence continue tomorrow!! Super pick y’all !!
👍️0
barnyarddog barnyarddog 11 months ago
Acorda Therapeutics and Chance Pharmaceuticals Announce Agreement to Commercialize INBRIJA® in China

Mon, May 8, 2023
https://finance.yahoo.com/news/acorda-therapeutics-chance-pharmaceuticals-announce-110000455.html
👍️0
81vette 81vette 11 months ago
ZERO BORROW now,should keep going,we shall see,i am holding until tomorrow no matter what,(have to run errands)
👍️0
INFINITI INFINITI 11 months ago
Nice got some
👍️0
81vette 81vette 11 months ago
loaded up,heading for ZERO BORROW now,running out of shares,only 7k left
👍️0
Mt. Blanc Mt. Blanc 1 year ago
ACOR supporting itself under the buck. In time more will get on board.

mb
👍️0
Mt. Blanc Mt. Blanc 1 year ago
ACOR with very thin trading. Should be trading in the low 1s pretty soon.

Off radar and can move quickly when news hits.

mb
👍️0
Mt. Blanc Mt. Blanc 1 year ago
ACOR One to keep on radar.

mb
👍️0
DK11 DK11 1 year ago
https://www.sec.gov/Archives/edgar/data/1008848/000119312522309544/d368917d8k.htm

They will take care of this soon
👍️0
Orphan Orphan 1 year ago
We spared ACOR, we permitted the reverse stock split because we believe in ACOR and they will do the right things
Your welcome from the wall streets bets Crew
👍️0
Orphan Orphan 1 year ago
They adjurned our meeting for today, ACOR the reverse stock split proposal is going to be voted no so let's not prolong your fate, wich is offer the shareholders a buy back or better or prepare to file your bankruptcy!!!!!!!!!

Most votes are in and it's no go for the reverse stock split !!!!!

Hear from you on November 11th for the meeting
👍️0
Orphan Orphan 1 year ago
Us retail shareholders own the largest portion of this stock , therefore if everyone votes we all know that the reverse split will be a no go!!!!!!, So I as an amc ape / wall streets bets Crew member am putting ACOR on notice prepare to file your bankruptcy or provide us all with a buyback or better.
I'm sure many can agree with me on this
👍️0
cash4 cash4 2 years ago
My friend owns 7 Townhouses in Valley Cottage, I know Rockland very well, I live in The Bronx.
👍️0
everton44 everton44 2 years ago
the company used to be right next door to my building, we use the same parking lot but they cut employees and moved a few months ago. The company used to be well maintained but hands on i saw that the let go of their staff and left westchester county in ny which is one of the most expensive county in the country to rockland county to save money as they were/are dying. they are trying to stay a float but did major cost cutting.
👍️0
cash4 cash4 2 years ago
I hope everyone votes against the R/S as I will, if I go bankrupt so should They, ...the reason they did not want to pay their debts is because bankruptcy will protect them from debts, therefore those they owe money to should exercise a hostile takeover and fire these clowns all together.

As of now the Market Cap dropped to 17 mil, if they want the stock above $1 they should announce a Buyback, they just got $16 mil in their bank the other day, always on the backs of lenders and shareholders, I'm so pissed with these crooks.

The same story with fly-by-night corporations, the losses are public but the profits are private, FOH,...they never share profits, only deficit.

Give me $16 mil and by the end of the trading day I would fire all of them on Zoom.
👍️0
cash4 cash4 2 years ago
This company is run by a bunch of clowns. You announce a Reverse Split proposal when you break $1 in just one day of trading from 34 cents, then you blackmail the shareholders to approve in voting if not you have to declare bankruptcy, when the company got more money awarded than the entire Market Cap is worth ? Bunch of assholes.

I wish some smart wale just buys up the entire free trading float and leaves them with just the 26% owned by the insiders to take this company to the next level.

24 mil shares float, what is the ratio going to be ? They want this stock to have only 2 Mil float ? Are they that stupid, 1st they announce they won't pay debts with shares to protect the shareholders from dilution and how's a Reverse Split going to protect us, morons.
👍️0
everton44 everton44 2 years ago
ACOR doing a reverse split soon, you heard it here first.
👍️0
BoilerRoom BoilerRoom 2 years ago
$RMED yes! Going be a good one imo
👍️0
Upgrader Upgrader 2 years ago
New out , no offering or dillution
👍️0
BoilerRoom BoilerRoom 2 years ago
Hope this turns back up today
👍️0
Invest-in-America Invest-in-America 2 years ago
ACOR: Simply follow BARCHART (free, see link below); & FIDELITY has an excellent (free) daily list of the top running stocks, which they call "MARKET MOVERS". However, in order to SEE Fidelity's important list, you have to OPEN an account with them --- but NO DEPOSIT MONEY is required (ever),
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
Invest-in-America Invest-in-America 2 years ago
ACOR: "Is this good?" Peeps love anything to do with LAWSUITS, bankruptcies, fraud investigations, etc., about ANY company. And, since evidently ACOR just WON a civil action of some nature, well, to the MOON --- at least for THIS particular day. (At this writing, ACOR is DOWN by 8.25% 'after hours', which is no big deal, per se.)

In any event, ACOR closed this day near the TOP of the following (very influential) LIST --- which everyone should follow every day. (Toss-away your silly 'Scanners'; stop 'following' mutha-duckas; & simply let BARCHART make you some bucks!!)
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc
/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
👍️0
subslover subslover 2 years ago
They are looking for NASDAQ compliance and I feel that they will get it. :)
👍️0
BoilerRoom BoilerRoom 2 years ago
$ACOR I’m all in here I need this to pop
👍️0
crudeoil24 crudeoil24 2 years ago
52 week high is 4.83 > The Multi-million dollars award putting ACOR on fast track to new 52 week highs.
👍️0
crudeoil24 crudeoil24 2 years ago
ACOR is a great $$$$$ opportunity.
👍️0
crudeoil24 crudeoil24 2 years ago
"This award will allow Acorda to obtain more competitive market rates for the supply of AMPYRA, significantly reducing our cost of goods and meaningfully increasing the product's value to the company," said Ron Cohen, M.D., Acorda's President and CEO. "This will also help Acorda to continue to provide its customary high level of support for Ampyra, ensuring that as many people with MS as possible may benefit from it."
👍️0
crudeoil24 crudeoil24 2 years ago
Acorda generating $938,000. revenue per employee this past year. Solid news today!
Plenty of upside ahead in upcoming sessions.
👍️0
subslover subslover 2 years ago
A Godzilla move today. Mothra shows up next!
👍️0
Actualfactual Actualfactual 2 years ago
Yeah….the poor guy who shorted it there…
👍️0
tedgoeseast tedgoeseast 2 years ago
Wow poor guy who bought 54,000 @ 1.04 down 20 percent already to .83, I can believe someone would buy when it is up over 170 percent ,will wait for about .75 dip tomorrow or lower I do think it will make it back up over .90
👍️0
BoilerRoom BoilerRoom 2 years ago
$ACOR $2.00 tomorrow
👍️0
BoilerRoom BoilerRoom 2 years ago
$ACOR all in here I think another 100% pop tomorrow
👍️0
BoilerRoom BoilerRoom 2 years ago
$ACOR I agree
👍️0
crudeoil24 crudeoil24 2 years ago
Should surpass 2.00+ by Wednesday. Day traders slowing down momo. Certainly great fundamental news putting ACOR on a higher revenue track.
👍️0
cash4 cash4 2 years ago
The stock traded its float 5 times over today.
👍️0

Your Recent History

Delayed Upgrade Clock